Pages that link to "Q26863283"
Jump to navigation
Jump to search
The following pages link to Therapeutic cancer vaccines: past, present, and future (Q26863283):
Displaying 50 items.
- RNA-Based Vaccines in Cancer Immunotherapy (Q26776028) (← links)
- Scavenger Receptors: Emerging Roles in Cancer Biology and Immunology (Q26799114) (← links)
- Anti-cancer vaccines - a one-hit wonder? (Q26995164) (← links)
- Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites? (Q28078539) (← links)
- Dendritic cell-based vaccine efficacy: aiming for hot spots (Q28082680) (← links)
- Milestones in contraceptive vaccines development and hurdles in their application (Q28601582) (← links)
- Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons (Q33684408) (← links)
- Combination therapy of cancer with cancer vaccine and immune checkpoint inhibitors: A mathematical model (Q33728672) (← links)
- ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1) (Q33772914) (← links)
- Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma (Q35768107) (← links)
- Superior Immunologic and Therapeutic Efficacy of a Xenogeneic Genetic Cancer Vaccine Targeting Carcinoembryonic Human Antigen. (Q35822301) (← links)
- Treatment with cyclophosphamide supported by various dendritic cell-based vaccines induces diversification in CD4⁺ T cell response against MC38 colon carcinoma (Q36498103) (← links)
- Viral-mimicking protein nanoparticle vaccine for eliciting anti-tumor responses. (Q36642808) (← links)
- The Five Immune Forces Impacting DNA-Based Cancer Immunotherapeutic Strategy. (Q37729321) (← links)
- Xenogene vaccination in the therapy of cancer (Q38229368) (← links)
- Cancer-related inflammation and treatment effectiveness (Q38256601) (← links)
- Antigen-specific vaccines for cancer treatment (Q38284692) (← links)
- Emerging immunotherapies for bladder cancer (Q38391811) (← links)
- Clinically feasible approaches to potentiating cancer cell-based immunotherapies. (Q38453610) (← links)
- Active immunization therapies for Parkinson's disease and multiple system atrophy (Q38564102) (← links)
- Immunotherapy for pancreatic cancer: present and future (Q38673158) (← links)
- Specific humoral and cellular immune responses in cancer patients undergoing chronic immunization with a VEGF-based therapeutic vaccine (Q38680054) (← links)
- Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches (Q38689153) (← links)
- A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo (Q38717131) (← links)
- The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response (Q38722460) (← links)
- Biointerfacing and Applications of Cell Membrane-Coated Nanoparticles (Q38734878) (← links)
- Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants (Q38759934) (← links)
- Cancer vaccine clinical trials (Q38780732) (← links)
- Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid Tumors (Q38904089) (← links)
- Review on the immunotherapy strategies against metastatic colorectal carcinoma. (Q38948909) (← links)
- Improved vaccine efficacy of tumor exosome compared to tumor lysate loaded dendritic cells in mice (Q38971206) (← links)
- Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma. (Q38972636) (← links)
- Cytokines in immunogenic cell death: Applications for cancer immunotherapy (Q39397491) (← links)
- Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma. (Q39415827) (← links)
- Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics (Q39829133) (← links)
- Therapeutic Cancer Vaccines (Q40728648) (← links)
- Enhanced immunity and antiviral effects of an HBV DNA vaccine delivered by a DC-targeting protein (Q40777038) (← links)
- Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine (Q42391387) (← links)
- Dendritic cells based immunotherapy (Q43043935) (← links)
- Creation of Recombinant Chaperone Vaccine Using Large Heat Shock Protein for Antigen-Targeted Cancer Immunotherapy (Q45074016) (← links)
- Virus like particles as a platform for cancer vaccine development. (Q45324534) (← links)
- Whole-Cell Cancer Vaccines Induce Large Antibody Responses to Carbohydrates and Glycoproteins (Q46767596) (← links)
- Protein Mimetic and Anticancer Properties of Monocyte-Targeting Peptide Amphiphile Micelles. (Q47147736) (← links)
- Informatics for cancer immunotherapy (Q47290509) (← links)
- Cancer immunotherapy beyond immune checkpoint inhibitors. (Q47554248) (← links)
- Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells. (Q47576731) (← links)
- Diagnostic and therapeutic applications of miRNA-based strategies to cancer immunotherapy. (Q47767814) (← links)
- Advances in ovarian cancer therapy (Q48104995) (← links)
- Cancer vaccine: learning lessons from immune checkpoint inhibitors (Q49260236) (← links)
- Combining Adoptive Cell Therapy with Cytomegalovirus-Based Vaccine Is Protective against Solid Skin Tumors (Q49364249) (← links)